Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study

BACKGROUND: The treatment of anemia in patients with cardiorenal syndrome (CRS) is based mainly on intravenous (IV) iron therapy and/or erythropoiesis-stimulating agents (ESAs). There are concerns about the safety of ESAs due to a potentially higher risk for stroke and malignancy. OBJECTIVE: We aime...

Full description

Saved in:
Bibliographic Details
Published in:Cardiorenal Med
Main Authors: Ben-Assa, Eyal, Shacham, Yacov, Shashar, Moshe, Leshem-Rubinow, Eran, Gal-Oz, Amir, Schwartz, Idit F., Schwartz, Doron, Silverberg, Donald S., Chernin, Gil
Format: Artigo
Language:Inglês
Published: S. Karger AG 2015
Subjects:
Original Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662275/
https://ncbi.nlm.nih.gov/pubmed/26648941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000433564
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items